Q4 2023 · 13F-HR
SECTOR GAMMA ASholdings as filed
Filed 2024-02-05 · accession 0000945621-24-000151
$412.1M
Reported value
30
Positions
2023-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| G5960L103 | MDT | MEDTRONIC PLC | $35.8M | 8.70% | 435,075 | Common | SOLE |
| 717081103 | PFE | PFIZER INC | $31.5M | 7.64% | 1,093,416 | Common | SOLE |
| 375558103 | GILD | GILEAD SCIENCES INC | $31.0M | 7.52% | 382,362 | Common | SOLE |
| 09062X103 | BIIB | BIOGEN INC | $26.5M | 6.42% | 102,234 | Common | SOLE |
| 45337C102 | INCY | INCYTE CORP | $25.0M | 6.07% | 398,699 | Common | SOLE |
| 110122108 | BMY | BRISTOL-MYERS SQUIBB CO | $19.2M | 4.66% | 374,687 | Common | SOLE |
| 36266G107 | GEHC | GE HEALTHCARE TECHNOLOGIES I | $19.1M | 4.64% | 247,531 | Common | SOLE |
| 126650100 | CVS | CVS HEALTH CORP | $17.3M | 4.20% | 219,000 | Common | SOLE |
| 98956P102 | ZBH | ZIMMER BIOMET HOLDINGS INC | $17.2M | 4.17% | 141,218 | Common | SOLE |
| 14149Y108 | CAH | CARDINAL HEALTH INC | $16.6M | 4.02% | 164,305 | Common | SOLE |
| 15135B101 | CNC | CENTENE CORP DEL | $16.1M | 3.90% | 216,416 | Common | SOLE |
| 88033G407 | THC | TENET HEALTHCARE CORP | $14.6M | 3.54% | 193,279 | Common | SOLE |
| 28176E108 | EW | EDWARDS LIFESCIENCES CORP | $14.3M | 3.47% | 187,556 | Common | SOLE |
| 036752103 | ELV | ELEVANCE HEALTH INC | $13.1M | 3.18% | 27,807 | Common | SOLE |
| 071813109 | BAX | BAXTER INTL INC | $12.7M | 3.08% | 328,132 | Common | SOLE |
| 379577208 | GMED | GLOBUS MED INC | $12.5M | 3.03% | 234,374 | Common | SOLE |
| 50540R409 | LSI | LABORATORY CORP AMER HLDGS | $11.5M | 2.80% | 50,686 | Common | SOLE |
| 116794108 | BRKR | BRUKER CORP | $9.4M | 2.27% | 127,312 | Common | SOLE |
| 09061G101 | BMRN | BIOMARIN PHARMACEUTICAL INC | $8.3M | 2.02% | 86,247 | Common | SOLE |
| N72482123 | — | QIAGEN NV | $8.3M | 2.01% | 190,539 | Common | SOLE |
| 090572207 | BIO | BIO RAD LABS INC | $7.6M | 1.85% | 23,609 | Common | SOLE |
| 462222100 | IONS | IONIS PHARMACEUTICALS INC | $7.3M | 1.78% | 145,012 | Common | SOLE |
| 02043Q107 | ALNY | ALNYLAM PHARMACEUTICALS INC | $6.1M | 1.49% | 32,092 | Common | SOLE |
| 004225108 | ACAD | ACADIA PHARMACEUTICALS INC | $5.9M | 1.43% | 188,111 | Common | SOLE |
| 452327109 | ILMN | ILLUMINA INC | $5.7M | 1.37% | 40,592 | Common | SOLE |
| G01767105 | ALKS | ALKERMES PLC | $5.5M | 1.35% | 200,000 | Common | SOLE |
| 90400D108 | RARE | ULTRAGENYX PHARMACEUTICAL IN | $4.9M | 1.19% | 102,490 | Common | SOLE |
| 002824100 | ABT | ABBOTT LABS | $4.4M | 1.06% | 39,876 | Common | SOLE |
| 516544103 | LNTH | LANTHEUS HLDGS INC | $3.2M | 0.79% | 52,316 | Common | SOLE |
| 92764N102 | VIR | VIR BIOTECHNOLOGY INC | $1.5M | 0.36% | 148,538 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.